SOHO 2023 Eleventh Annual Meeting
Avatar

SOHO 2023: Treatment Options for Marginal Zone Lymphoma

By SOHO 2023 Eleventh Annual Meeting FEATURING Emanuele Zucca
By SOHO 2023 Eleventh Annual Meeting FEATURING Emanuele Zucca
55 views
October 18, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Related Content

AUTOPLAY
08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
03:42
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BELLWAVE-003 - A Phase 2 Dose Escalation,…

Feat. G. Perini
11:12
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: Indolent B-Cell Lymphoma

Feat. L. Nastoupil
14:36
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

The Latest Data on New Therapies in FL and MZL

Feat. J. Carter
11:42
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Impact of Large Cells and Ki-67% on Outcome…

Feat. N. Epperla
22:53
SOHO Turkey 2023

SOHO Turkey 2023: Marginal Zone Lymphoma & Mantle Cell Lymphoma

Feat. O. Hermine
17:41
5th SOHO Italy Annual Conference

SOHO Italy 2023: How I Manage Follicular, Marginal Zone and Mantle C…

Feat. S. Luminari
21:46
SOHO 2022 Tenth Annual Meeting

SOHO 2022: CAR T-Cells in Indolent B-Cell Lymphomas

Feat. J. Abramson
08:51
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Long-Term Outcomes After Haplo-SCT for Hematologic Malign…

Feat. S. Saengboon
08:34
ASH 2022 Conference Coverage

ASH 2022: Zanubrutinib in Acalabrutinib-Intolerant Patients With B-C…

Feat. M. Shadman
19:21
SOHO Brazil 2023

2023 SOHO® Brazil: "CAR-T Therapy in MCL, FL, and MZL"

Feat. B. Shah
02:18
Insights from 2023 EHA® Annual Meeting

2023 EHA® Insights: "Matching-Adjusted Indirect Comparison of Z…

Feat. C. Thieblemont
16:31
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

Advances in Follicular and Marginal Zone Lymphomas

Feat. J. Carter
18:35
SOHO Brazil 2023

2023 SOHO® Brazil: "Problems on the Horizon - When MZL Goes Bad…

Feat. J. Alderuccio
05:39
ecancer

ASH 2023 Insights: "Ilyad Trial - Vitamin D Intervention in Pat…

Feat. J. Friedberg